DK0974111T3 - Apparatus and method for automated protein design - Google Patents

Apparatus and method for automated protein design

Info

Publication number
DK0974111T3
DK0974111T3 DK98915478T DK98915478T DK0974111T3 DK 0974111 T3 DK0974111 T3 DK 0974111T3 DK 98915478 T DK98915478 T DK 98915478T DK 98915478 T DK98915478 T DK 98915478T DK 0974111 T3 DK0974111 T3 DK 0974111T3
Authority
DK
Denmark
Prior art keywords
protein design
automated protein
automated
design
protein
Prior art date
Application number
DK98915478T
Other languages
Danish (da)
Inventor
Stephen Mayo
Bassil I Dahiyat
D Benjamin Gordon
Arthur Street
Original Assignee
California Inst Of Techn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Inst Of Techn filed Critical California Inst Of Techn
Application granted granted Critical
Publication of DK0974111T3 publication Critical patent/DK0974111T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1089—Design, preparation, screening or analysis of libraries using computer algorithms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/003—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by transforming the C-terminal amino acid to amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/20—Protein or domain folding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
DK98915478T 1997-04-11 1998-04-10 Apparatus and method for automated protein design DK0974111T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4346497P 1997-04-11 1997-04-11
US5467897P 1997-08-04 1997-08-04
US6109797P 1997-10-03 1997-10-03
PCT/US1998/007254 WO1998047089A1 (en) 1997-04-11 1998-04-10 Apparatus and method for automated protein design

Publications (1)

Publication Number Publication Date
DK0974111T3 true DK0974111T3 (en) 2003-04-22

Family

ID=27366337

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98915478T DK0974111T3 (en) 1997-04-11 1998-04-10 Apparatus and method for automated protein design

Country Status (8)

Country Link
US (11) US6188965B1 (en)
EP (1) EP0974111B1 (en)
JP (1) JP2002510966A (en)
AU (1) AU751331B2 (en)
CA (1) CA2286262A1 (en)
DE (1) DE69810603T2 (en)
DK (1) DK0974111T3 (en)
WO (1) WO1998047089A1 (en)

Families Citing this family (190)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7047171B1 (en) * 1995-12-08 2006-05-16 Sproch Norman K Method for the characterization of the three-dimensional structure of proteins employing mass spectrometric analysis and computational feedback modeling
US20060277017A1 (en) * 1993-11-04 2006-12-07 Sproch Norman K Method for the characterization of the three-dimensional structure of proteins employing mass spectrometric analysis and computational feedback modeling
JP2002510966A (en) * 1997-04-11 2002-04-09 カリフォルニア・インスティテュート・オブ・テクノロジー Apparatus and method for automatic protein design
US20030049654A1 (en) * 1998-10-16 2003-03-13 Xencor Protein design automation for protein libraries
US20020048772A1 (en) * 2000-02-10 2002-04-25 Dahiyat Bassil I. Protein design automation for protein libraries
US6403312B1 (en) 1998-10-16 2002-06-11 Xencor Protein design automatic for protein libraries
WO2000023564A2 (en) * 1998-10-16 2000-04-27 Xencor, Inc. Protein design automation for protein libraries
US7315786B2 (en) 1998-10-16 2008-01-01 Xencor Protein design automation for protein libraries
US6627186B1 (en) 1999-01-06 2003-09-30 Xencor Nucleic acids and protein variants of hG-CSF with granulopoietic activity
US7208473B2 (en) 1999-01-06 2007-04-24 Xencor, Inc. Nucleic acids and protein variants of hG-CSF with granulopoietic activity
WO2000042559A1 (en) * 1999-01-18 2000-07-20 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US7024312B1 (en) * 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
EP1108783A3 (en) 1999-01-19 2001-09-05 Maxygen, Inc. Oligonucleotide-mediated nucleic acid recombination
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
US20070065838A1 (en) * 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US7873477B1 (en) 2001-08-21 2011-01-18 Codexis Mayflower Holdings, Llc Method and system using systematically varied data libraries
US8457903B1 (en) 1999-01-19 2013-06-04 Codexis Mayflower Holdings, Llc Method and/or apparatus for determining codons
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
AU2880800A (en) * 1999-02-11 2000-08-29 Xencor, Inc. Structure-based screening techniques for drug discovery
US6864359B1 (en) 1999-02-11 2005-03-08 Xencor Structure-based screening techniques for drug discovery
JP3892167B2 (en) * 1999-03-19 2007-03-14 富士通株式会社 Generation apparatus and method for generating arrangement of particle population
US6343257B1 (en) 1999-04-23 2002-01-29 Peptor Ltd. Identifying pharmacophore containing combinations of scaffold molecules and substituents from a virtual library
US6514729B1 (en) * 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
EP1179075A2 (en) * 1999-05-12 2002-02-13 Xencor, Inc. Bacillus circulans xylanase mutants
US6682923B1 (en) 1999-05-12 2004-01-27 Xencor Thermostable alkaliphilic xylanase
CA2372871A1 (en) * 1999-05-12 2000-11-16 Xencor, Inc. Novel nucleic acids and proteins with growth hormone activity
US6946265B1 (en) 1999-05-12 2005-09-20 Xencor, Inc. Nucleic acids and proteins with growth hormone activity
US6334099B1 (en) * 1999-05-25 2001-12-25 Digital Gene Technologies, Inc. Methods for normalization of experimental data
EP1222603A2 (en) * 1999-09-01 2002-07-17 California Institute of Technology Methods and compositions utilizing a branch and terminate algorithm for protein design
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
ATE341793T1 (en) * 1999-11-03 2006-10-15 Algonomics N V METHOD FOR GENERATING INFORMATION RELATED TO THE MOLECULAR STRUCTURE OF A BIOMOLECULE
WO2001037147A2 (en) * 1999-11-03 2001-05-25 Algonomics Nv Apparatus and method for structure-based prediction of amino acid sequences
CA2391987A1 (en) * 1999-11-22 2001-05-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem System and method for searching a combinatorial space
JP3964087B2 (en) * 1999-12-24 2007-08-22 株式会社カネカ Method and apparatus for calculating optimized solution of multiple mutant protein amino acid sequence, and storage medium storing program for executing processing of this method
US7462354B2 (en) * 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
EP1255826B1 (en) * 2000-02-10 2005-09-14 Xencor Protein design automation for protein libraries
EP1621617A1 (en) * 2000-02-10 2006-02-01 Xencor, Inc. Protein design automation for protein libraries
US20070172449A1 (en) * 2000-03-02 2007-07-26 Xencor, Inc. TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS
US7056695B2 (en) 2000-03-02 2006-06-06 Xencor TNF-α variants
US7687461B2 (en) * 2000-03-02 2010-03-30 Xencor, Inc. Treatment of TNF-α related disorders with TNF-α variant proteins
US7101974B2 (en) * 2000-03-02 2006-09-05 Xencor TNF-αvariants
US7244823B2 (en) * 2000-03-02 2007-07-17 Xencor TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
US7446174B2 (en) 2001-03-02 2008-11-04 Xencor, Inc. Protein based TNF-α variants for the treatment of TNF-α related disorders
EP1259616A2 (en) * 2000-03-02 2002-11-27 Xencor Tnf-alpha variants for the treatment of tnf-alpha related disorders
US7662367B2 (en) 2000-03-02 2010-02-16 Xencor, Inc. Pharmaceutical compositions for the treatment of TNF-α related disorders
US6983233B1 (en) 2000-04-19 2006-01-03 Symyx Technologies, Inc. Combinatorial parameter space experiment design
AU2001263445A1 (en) * 2000-05-24 2001-12-03 California Institute Of Technology Methods for protein design
US6586207B2 (en) * 2000-05-26 2003-07-01 California Institute Of Technology Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
DE10028875A1 (en) * 2000-06-10 2001-12-20 Hte Gmbh Automatic formation and iterative optimization of substance library, employs integrated process embracing manufacture, performance testing, and test result analysis
AU2001282880A1 (en) 2000-07-07 2002-01-21 California Institute Of Technology Proteins with integrin-like activity
JP2004502946A (en) * 2000-07-10 2004-01-29 ゼンコー Protein design automation for designing protein libraries with altered immunogenicity
IL137886A0 (en) 2000-08-16 2001-10-31 Univ Ramot A novel algorithm for de novo protein design
WO2002014875A2 (en) * 2000-08-16 2002-02-21 Ramot University Authority For Applied Research & Industrial Development Ltd. Method and system for predicting amino acid sequence
WO2002038746A2 (en) * 2000-11-10 2002-05-16 Xencor Novel thermostable alkaliphilic xylanase
CA2431066C (en) * 2000-12-15 2007-05-15 Youqi Wang Methods and apparatus for designing high-dimensional combinatorial experiments
US20030036854A1 (en) * 2001-02-06 2003-02-20 The Penn State Research Foundation Apparatus and method for designing proteins and protein libraries
US7231328B2 (en) * 2001-02-06 2007-06-12 The Penn State Research Foundation Apparatus and method for designing proteins and protein libraries
US20020183937A1 (en) * 2001-02-09 2002-12-05 Stephen Mayo Method for the generation of proteins with new enzymatic function
WO2002073193A1 (en) * 2001-03-12 2002-09-19 Board Of Regents, The University Of Texas System Computer-based strategy for peptide and protein conformational ensemble enumeration and ligand affinity analysis
EP1419428A4 (en) * 2001-03-12 2005-03-02 Regents Board Of Ensemble-based strategy for the design of protein pharmaceuticals
US20030211511A1 (en) * 2001-05-04 2003-11-13 Briggs Steven P. Nucleic acids and proteins with thioredoxin reductase activity
US7071307B2 (en) 2001-05-04 2006-07-04 Syngenta Participations Ag Nucleic acids and proteins with thioredoxin reductase activity
US20030049680A1 (en) * 2001-05-24 2003-03-13 Gordon D. Benjamin Methods and compositions utilizing hybrid exact rotamer optimization algorithms for protein design
US7110525B1 (en) 2001-06-25 2006-09-19 Toby Heller Agent training sensitive call routing system
US20030022285A1 (en) * 2001-07-10 2003-01-30 Chirino Arthur J. Protein design automation for designing protein libraries with altered immunogenicity
EP1482433A3 (en) * 2001-08-10 2006-04-12 Xencor, Inc. Protein design automation for protein libraries
WO2003014325A2 (en) * 2001-08-10 2003-02-20 Xencor Protein design automation for protein libraries
EP1430428A2 (en) * 2001-08-31 2004-06-23 Optimum Power Technology, L.P. Design optimization
US6822073B2 (en) * 2001-12-20 2004-11-23 Kimberly-Clark Worldwide, Inc. Modular peptide-based reagent
US7381792B2 (en) * 2002-01-04 2008-06-03 Xencor, Inc. Variants of RANKL protein
WO2003073238A2 (en) * 2002-02-27 2003-09-04 California Institute Of Technology Computational method for designing enzymes for incorporation of amino acid analogs into proteins
AU2003217912A1 (en) * 2002-03-01 2003-09-16 Xencor Antibody optimization
US20080254027A1 (en) * 2002-03-01 2008-10-16 Bernett Matthew J Optimized CD5 antibodies and methods of using the same
US20040132101A1 (en) 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
US20070148171A1 (en) * 2002-09-27 2007-06-28 Xencor, Inc. Optimized anti-CD30 antibodies
US7662925B2 (en) * 2002-03-01 2010-02-16 Xencor, Inc. Optimized Fc variants and methods for their generation
US20080260731A1 (en) * 2002-03-01 2008-10-23 Bernett Matthew J Optimized antibodies that target cd19
US7317091B2 (en) * 2002-03-01 2008-01-08 Xencor, Inc. Optimized Fc variants
US8188231B2 (en) 2002-09-27 2012-05-29 Xencor, Inc. Optimized FC variants
EP1488364B1 (en) * 2002-03-26 2008-11-05 Council of Scientific and Industrial Research Method and system to build optimal models of 3-dimensional molecular structures
AU2003220559A1 (en) * 2002-03-26 2003-10-13 Carnegie Mellon University Methods and systems for molecular modeling
WO2003087310A2 (en) * 2002-04-04 2003-10-23 California Institute Of Technology Directed protein docking algorithm
US7272545B2 (en) * 2002-05-22 2007-09-18 General Electric Company Method and apparatus for designing and locating chemical structures
EP1522037A2 (en) * 2002-05-23 2005-04-13 Board Of Regents The University Of Texas System Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
WO2004003683A2 (en) * 2002-07-01 2004-01-08 3-Dimensional Pharmaceuticals, Inc. Conformational sampling by self-organization
DE10233047A1 (en) * 2002-07-19 2004-02-26 Amaxa Gmbh Preparing synthetic polypeptides, particularly fluorescent proteins, useful in pharmaceutical compositions, by aligning sequences of known proteins to define an average sequence
US20040082783A1 (en) * 2002-08-06 2004-04-29 Schafmeister Christian E. Bis (amino acid) molecular scaffolds
US20060235208A1 (en) * 2002-09-27 2006-10-19 Xencor, Inc. Fc variants with optimized properties
BRPI0314814C1 (en) 2002-09-27 2021-07-27 Xencor Inc antibody comprising an fc variant
US20040175359A1 (en) * 2002-11-12 2004-09-09 Desjarlais John Rudolph Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity
US20050130892A1 (en) * 2003-03-07 2005-06-16 Xencor, Inc. BAFF variants and methods thereof
US20060014248A1 (en) * 2003-01-06 2006-01-19 Xencor, Inc. TNF super family members with altered immunogenicity
US7553930B2 (en) * 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
US20050221443A1 (en) * 2003-01-06 2005-10-06 Xencor, Inc. Tumor necrosis factor super family agonists
AU2004204942A1 (en) * 2003-01-08 2004-07-29 Xencor, Inc Novel proteins with altered immunogenicity
PT1586059E (en) * 2003-01-20 2010-05-28 Cambridge Entpr Ltd Computational method and apparatus for predicting polypeptide aggregation or solubility
US20040215400A1 (en) * 2003-01-21 2004-10-28 The Trustees Of The University Of Pennsylvania Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel KcsA
US9818136B1 (en) 2003-02-05 2017-11-14 Steven M. Hoffberg System and method for determining contingent relevance
US20040176585A1 (en) * 2003-02-27 2004-09-09 Carter Richard J. Method and system for determining optimal sequences
US8084582B2 (en) 2003-03-03 2011-12-27 Xencor, Inc. Optimized anti-CD20 monoclonal antibodies having Fc variants
US20090010920A1 (en) * 2003-03-03 2009-01-08 Xencor, Inc. Fc Variants Having Decreased Affinity for FcyRIIb
US20070275460A1 (en) * 2003-03-03 2007-11-29 Xencor.Inc. Fc Variants With Optimized Fc Receptor Binding Properties
US8388955B2 (en) * 2003-03-03 2013-03-05 Xencor, Inc. Fc variants
AU2004227937B2 (en) * 2003-03-31 2007-09-20 Xencor, Inc Methods for rational pegylation of proteins
US7642340B2 (en) 2003-03-31 2010-01-05 Xencor, Inc. PEGylated TNF-α variant proteins
US7610156B2 (en) 2003-03-31 2009-10-27 Xencor, Inc. Methods for rational pegylation of proteins
US9051373B2 (en) 2003-05-02 2015-06-09 Xencor, Inc. Optimized Fc variants
WO2005007806A2 (en) * 2003-05-07 2005-01-27 Duke University Protein design for receptor-ligand recognition and binding
US20050064555A1 (en) * 2003-07-09 2005-03-24 Xencor, Inc. Ciliary neurotrophic factor variants
WO2005052839A2 (en) * 2003-07-29 2005-06-09 California Institute Of Technology Systems and methods for predicting transmembrane domains in membrane proteins and mining the genome for recognizing g-protein coupled receptors
WO2005017805A2 (en) * 2003-08-13 2005-02-24 California Institute Of Technology Systems and methods for predicting the structure and function of multipass transmembrane proteins
US20050065879A1 (en) * 2003-09-18 2005-03-24 Convergys Information Management Group, Inc. System and method for web service billing
US7765175B2 (en) * 2003-09-18 2010-07-27 Optimum Power Technology, L.P. Optimization expert system
US9714282B2 (en) 2003-09-26 2017-07-25 Xencor, Inc. Optimized Fc variants and methods for their generation
US8101720B2 (en) 2004-10-21 2012-01-24 Xencor, Inc. Immunoglobulin insertions, deletions and substitutions
EP2327723A3 (en) 2003-10-10 2012-06-27 Xencor, Inc. Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
EP1673466B1 (en) * 2003-10-14 2012-06-06 Verseon Method and apparatus for analysis of molecular combination based on computational estimation of electrostatic affinity using basis expansions
US20070149496A1 (en) * 2003-10-31 2007-06-28 Jack Tuszynski Water-soluble compound
US20070122864A1 (en) * 2003-11-05 2007-05-31 The Regents Of The University Of California Methods for the determination of protein three-dimensional structure employing hydrogen exchange analysis to refine computational structure prediction
GB0325817D0 (en) * 2003-11-05 2003-12-10 Univ Cambridge Tech Method and apparatus for assessing polypeptide aggregation
US20070118296A1 (en) * 2003-11-07 2007-05-24 Dna Software Inc. System and methods for three dimensional molecular structural analysis
US7574306B1 (en) * 2003-11-20 2009-08-11 University Of Washington Method and system for optimization of polymer sequences to produce polymers with stable, 3-dimensional conformations
WO2005056759A2 (en) 2003-12-04 2005-06-23 Xencor, Inc. Methods of generating variant proteins with increased host string content and compositions thereof
US20060122783A1 (en) * 2004-08-24 2006-06-08 Ishikawa Muriel Y System and method for heightening a humoral immune response
US20060003412A1 (en) * 2003-12-08 2006-01-05 Xencor, Inc. Protein engineering with analogous contact environments
US20070249809A1 (en) * 2003-12-08 2007-10-25 Xencor, Inc. Protein engineering with analogous contact environments
WO2005077981A2 (en) * 2003-12-22 2005-08-25 Xencor, Inc. Fc POLYPEPTIDES WITH NOVEL Fc LIGAND BINDING SITES
AU2005227326B2 (en) * 2004-03-24 2009-12-03 Xencor, Inc. Immunoglobulin variants outside the Fc region
US20050260711A1 (en) * 2004-03-30 2005-11-24 Deepshikha Datta Modulating pH-sensitive binding using non-natural amino acids
WO2005109158A2 (en) * 2004-05-05 2005-11-17 Massachusetts Institute Of Technology Methods and systems for generating peptides
US20050287639A1 (en) 2004-05-17 2005-12-29 California Institute Of Technology Methods of incorporating amino acid analogs into proteins
US20050266464A1 (en) * 2004-05-21 2005-12-01 Xencor, Inc. C1q family member proteins with altered immunogenicity
US20150010550A1 (en) 2004-07-15 2015-01-08 Xencor, Inc. OPTIMIZED Fc VARIANTS
US20060074225A1 (en) * 2004-09-14 2006-04-06 Xencor, Inc. Monomeric immunoglobulin Fc domains
US20060136139A1 (en) * 2004-10-12 2006-06-22 Elcock Adrian H Rapid computational identification of targets
CA2585453C (en) * 2004-10-28 2020-02-18 Cerno Bioscience Llc Qualitative and quantitative mass spectral analysis
US8546543B2 (en) 2004-11-12 2013-10-01 Xencor, Inc. Fc variants that extend antibody half-life
US8802820B2 (en) 2004-11-12 2014-08-12 Xencor, Inc. Fc variants with altered binding to FcRn
US20070135620A1 (en) * 2004-11-12 2007-06-14 Xencor, Inc. Fc variants with altered binding to FcRn
US8367805B2 (en) * 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
DK2325207T3 (en) 2004-11-12 2017-06-06 Xencor Inc Fc variants with altered binding to FcRn
EP1858925A2 (en) * 2005-01-12 2007-11-28 Xencor, Inc. Antibodies and fc fusion proteins with altered immunogenicity
WO2006094234A1 (en) * 2005-03-03 2006-09-08 Xencor, Inc. Methods for the design of libraries of protein variants
US20080207467A1 (en) * 2005-03-03 2008-08-28 Xencor, Inc. Methods for the design of libraries of protein variants
RU2421462C2 (en) 2005-07-29 2011-06-20 Таргитид Гроус, Инк. Protective action of dominant-negative mutant protein krp from inhibiting wild-type active complex cyclin-cdk krp
WO2007030594A2 (en) * 2005-09-07 2007-03-15 Board Of Regents, The University Of Texas System Methods of using and analyzing biological sequence data
WO2007038414A2 (en) * 2005-09-27 2007-04-05 Indiana University Research & Technology Corporation Mining protein interaction networks
CA2624189A1 (en) * 2005-10-03 2007-04-12 Xencor, Inc. Fc variants with optimized fc receptor binding properties
JP4860703B2 (en) 2005-10-06 2012-01-25 ゼンコー・インコーポレイテッド Optimized anti-CD30 antibody
ES2317819T1 (en) * 2005-11-03 2009-05-01 Redpoint Bio Corporation HIGH PERFORMANCE DETECTION TEST FOR THE TRPM5 ION CHANNEL.
WO2007061850A2 (en) * 2005-11-17 2007-05-31 Massachusetts Institute Of Technology Methods and systems for generating and evaluating peptides
SI1999259T1 (en) 2006-03-03 2014-11-28 California Institute Of Technology Site-specific incorporation of amino acids into molecules
US20070208411A1 (en) * 2006-03-06 2007-09-06 Boston Scientific Scimed, Inc. Bifurcated stent with surface area gradient
US20070254307A1 (en) * 2006-04-28 2007-11-01 Verseon Method for Estimation of Location of Active Sites of Biopolymers Based on Virtual Library Screening
CA2653748A1 (en) 2006-05-02 2007-11-15 Allozyne, Inc. Non-natural amino acid substituted polypeptides
US20080096819A1 (en) * 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
JP5448447B2 (en) * 2006-05-26 2014-03-19 国立大学法人京都大学 Predict protein-compound interactions and rational design of compound libraries based on chemical genome information
WO2008013861A2 (en) * 2006-07-27 2008-01-31 Redpoint Bio Corporation Screening assay for inhibitors of trpa1 activation by a lower alkyl phenol
ES2457072T3 (en) 2006-08-14 2014-04-24 Xencor, Inc. Optimized antibodies that select as target CD19
CA2660795C (en) * 2006-09-18 2014-11-18 Xencor, Inc. Optimized antibodies that target hm1.24
CA2685596A1 (en) 2007-05-02 2008-11-13 Ambrx, Inc. Modified interferon beta polypeptides and their uses
US7580304B2 (en) * 2007-06-15 2009-08-25 United Memories, Inc. Multiple bus charge sharing
CA2707840A1 (en) * 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
WO2009045377A2 (en) * 2007-10-01 2009-04-09 Redpoint Bio Corporation A non-desensitizing mutant of the transient receptor potential trpm5 ion channel
JP5547083B2 (en) 2007-11-20 2014-07-09 アンブルックス，インコーポレイテッド Modified insulin polypeptides and their use
EP4098661A1 (en) 2007-12-26 2022-12-07 Xencor, Inc. Fc variants with altered binding to fcrn
WO2009149218A2 (en) * 2008-06-03 2009-12-10 Codon Devices, Inc. Novel proteins and methods of designing and using same
PE20110426A1 (en) 2008-07-23 2011-07-01 Ambrx Inc MODIFIED BOVINE G-CSF POLYPEPTIDES
US20110318322A1 (en) 2009-01-12 2011-12-29 Nektar Therapeutics Conjugates of a Lysosomal Enzyme Moiety and a Water Soluble Polymer
US20120148604A1 (en) 2009-08-20 2012-06-14 Transposagen Biopharmaceuticals, Inc. Trp inhibitors and uses thereof
WO2011028952A1 (en) 2009-09-02 2011-03-10 Xencor, Inc. Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
CA2784793A1 (en) 2009-12-21 2011-07-21 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
SG181769A1 (en) 2009-12-21 2012-07-30 Ambrx Inc Modified porcine somatotropin polypeptides and their uses
US8362210B2 (en) 2010-01-19 2013-01-29 Xencor, Inc. Antibody variants with enhanced complement activity
EP2605789B1 (en) 2010-08-17 2019-06-05 Ambrx, Inc. Modified relaxin polypeptides and their uses
AR083006A1 (en) 2010-09-23 2013-01-23 Lilly Co Eli FORMULATIONS FOR THE STIMULATING FACTOR OF COLONIES OF GRANULOCITS (G-CSF) BOVINE AND VARIANTS OF THE SAME
LT2790687T (en) 2011-12-16 2018-12-10 Poseida Therapeutics, Inc. Trpc4 modulators for use in the treatment or prevention of pain
US20130252280A1 (en) * 2012-03-07 2013-09-26 Genformatic, Llc Method and apparatus for identification of biomolecules
WO2014144963A1 (en) * 2013-03-15 2014-09-18 Alexandre Zanghellini Automated method of computational enzyme identification and design
WO2014201566A1 (en) * 2013-06-21 2014-12-24 Zymeworks Inc. Systems and methods for physical parameter fitting on the basis of manual review
US10381326B2 (en) 2014-05-28 2019-08-13 Invensas Corporation Structure and method for integrated circuits packaging with increased density
EP3436470A4 (en) 2016-04-01 2019-11-20 University of Washington Polypeptides capable of forming homo-oligomers with modular hydrogen bond network-mediated specificity and their design
WO2019125732A1 (en) 2017-12-19 2019-06-27 Xencor, Inc. Engineered il-2 fc fusion proteins
US20190325986A1 (en) * 2018-04-24 2019-10-24 Samsung Electronics Co., Ltd. Method and device for predicting amino acid substitutions at site of interest to generate enzyme variant optimized for biochemical reaction
FI3849614T3 (en) 2018-09-11 2024-02-08 Ambrx Inc Interleukin-2 polypeptide conjugates and their uses
US20220009986A1 (en) 2018-10-19 2022-01-13 Ambrx, Inc. Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
AU2021233909A1 (en) 2020-03-11 2022-09-29 Ambrx, Inc. Interleukin-2 polypeptide conjugates and methods of use thereof
CN114495243B (en) * 2022-04-06 2022-07-05 第六镜科技(成都)有限公司 Image recognition model training and image recognition method and device, and electronic equipment

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939666A (en) * 1987-09-02 1990-07-03 Genex Corporation Incremental macromolecule construction methods
US5527681A (en) 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
US5265030A (en) * 1990-04-24 1993-11-23 Scripps Clinic And Research Foundation System and method for determining three-dimensional structures of proteins
US5241470A (en) * 1992-01-21 1993-08-31 The Board Of Trustees Of The Leland Stanford University Prediction of protein side-chain conformation by packing optimization
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5878373A (en) * 1996-12-06 1999-03-02 Regents Of The University Of California System and method for determining three-dimensional structure of protein sequences
GB9701425D0 (en) 1997-01-24 1997-03-12 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
JP2002510966A (en) * 1997-04-11 2002-04-09 カリフォルニア・インスティテュート・オブ・テクノロジー Apparatus and method for automatic protein design
US20020048772A1 (en) * 2000-02-10 2002-04-25 Dahiyat Bassil I. Protein design automation for protein libraries
US20030049654A1 (en) * 1998-10-16 2003-03-13 Xencor Protein design automation for protein libraries
US6403312B1 (en) * 1998-10-16 2002-06-11 Xencor Protein design automatic for protein libraries
US7315786B2 (en) * 1998-10-16 2008-01-01 Xencor Protein design automation for protein libraries
WO2000023564A2 (en) 1998-10-16 2000-04-27 Xencor, Inc. Protein design automation for protein libraries
EP1179075A2 (en) 1999-05-12 2002-02-13 Xencor, Inc. Bacillus circulans xylanase mutants
EP1255826B1 (en) 2000-02-10 2005-09-14 Xencor Protein design automation for protein libraries
WO2003014325A2 (en) * 2001-08-10 2003-02-20 Xencor Protein design automation for protein libraries

Also Published As

Publication number Publication date
CA2286262A1 (en) 1998-10-22
JP2002510966A (en) 2002-04-09
US6801861B2 (en) 2004-10-05
US20060259247A1 (en) 2006-11-16
US20020004706A1 (en) 2002-01-10
WO1998047089A1 (en) 1998-10-22
US6792356B2 (en) 2004-09-14
US6708120B1 (en) 2004-03-16
US6269312B1 (en) 2001-07-31
DE69810603T2 (en) 2003-11-13
US20060019316A1 (en) 2006-01-26
US6188965B1 (en) 2001-02-13
DE69810603D1 (en) 2003-02-13
US20070032961A1 (en) 2007-02-08
US20010039480A1 (en) 2001-11-08
EP0974111B1 (en) 2003-01-08
US20020106694A1 (en) 2002-08-08
AU751331B2 (en) 2002-08-15
EP0974111A1 (en) 2000-01-26
US20010032052A1 (en) 2001-10-18
AU6965498A (en) 1998-11-11
US6950754B2 (en) 2005-09-27
US20050038610A1 (en) 2005-02-17
US6804611B2 (en) 2004-10-12

Similar Documents

Publication Publication Date Title
DK0974111T3 (en) Apparatus and method for automated protein design
DK0881354T3 (en) Method and apparatus for cementing a well
NO994729D0 (en) Method and apparatus for friction welding
DK1005775T3 (en) Method and apparatus for planning the opposite link speed
DK1064094T3 (en) Apparatus for coating monolithic supports and their method
DK0827696T4 (en) Method and apparatus for forming a nutrient
DK47193D0 (en) METHOD AND APPARATUS FOR FIXING PIGS
NO993498L (en) Apparatus and method for aligning pipes
DK0956732T3 (en) Method and apparatus for performing the bleed-on in a wireless communication system
DK1508666T3 (en) Method and apparatus for completing wells with side branches
NO981426D0 (en) Method and apparatus for primary-well cementing
NO994638L (en) Method and apparatus for routing short messages
DK0762067T3 (en) Method and apparatus for preventing agglomeration
DK1027208T3 (en) Method and apparatus for activating an article
DK0770854T3 (en) Method, apparatus and system for determining samples
DK15994A (en) Method and apparatus for cleaning tank space
DK0853309T3 (en) Method and apparatus for signal analysis
NO972578D0 (en) Sealing method and apparatus
DK0923428T3 (en) Method and apparatus for making abrasive tools
DK0958043T3 (en) Apparatus and method for treating particulate materials
DK0806356T3 (en) Process and apparatus for de-oxygenating food packaging
DK1034138T3 (en) Apparatus and method for purifying water
DK0960971T3 (en) Method and apparatus for folding garments
NO995567D0 (en) Method and apparatus for collaboration
DK37497A (en) Apparatus and method for processing photographic material